
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current status of immune checkpoint inhibitors for gastric cancer
Koji Kono, Shotaro Nakajima, Kosaku Mimura
Gastric Cancer (2020) Vol. 23, Iss. 4, pp. 565-578
Open Access | Times Cited: 193
Koji Kono, Shotaro Nakajima, Kosaku Mimura
Gastric Cancer (2020) Vol. 23, Iss. 4, pp. 565-578
Open Access | Times Cited: 193
Showing 1-25 of 193 citing articles:
Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
Zirui Zhao, Haohan Liu, Xingyu Zhou, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 174
Zirui Zhao, Haohan Liu, Xingyu Zhou, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 174
Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing
Haiping Jiang, Dingyi Yu, Penghui Yang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 151
Haiping Jiang, Dingyi Yu, Penghui Yang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 151
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
Xin Jin, Zhaorui Liu, Dongxiao Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Xin Jin, Zhaorui Liu, Dongxiao Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer
Xingyu Zhou, Deliang Fang, Haohan Liu, et al.
Cancer Letters (2022) Vol. 532, pp. 215598-215598
Closed Access | Times Cited: 86
Xingyu Zhou, Deliang Fang, Haohan Liu, et al.
Cancer Letters (2022) Vol. 532, pp. 215598-215598
Closed Access | Times Cited: 86
Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge
Wing Sum Shin, Fuda Xie, Bonan Chen, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2639-2639
Open Access | Times Cited: 57
Wing Sum Shin, Fuda Xie, Bonan Chen, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2639-2639
Open Access | Times Cited: 57
Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer
Cong Chen, Yanmei Gu, Fan Zhang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 61
Cong Chen, Yanmei Gu, Fan Zhang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 61
Recent Progress in Immunotherapy for Gastric Cancer
Jeesun Yoon, Tae‐Yong Kim, Do‐Youn Oh
Journal of the Korean Gastric Cancer Association (2023) Vol. 23, Iss. 1, pp. 207-207
Open Access | Times Cited: 29
Jeesun Yoon, Tae‐Yong Kim, Do‐Youn Oh
Journal of the Korean Gastric Cancer Association (2023) Vol. 23, Iss. 1, pp. 207-207
Open Access | Times Cited: 29
Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression
Sepideh Mirzaei, Mohammad Gholami, Hamid Asadzadeh Aghdaei, et al.
Environmental Research (2023) Vol. 231, pp. 116115-116115
Closed Access | Times Cited: 24
Sepideh Mirzaei, Mohammad Gholami, Hamid Asadzadeh Aghdaei, et al.
Environmental Research (2023) Vol. 231, pp. 116115-116115
Closed Access | Times Cited: 24
Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway
Guang Chen, Huhu Zhang, Hongxiao Sun, et al.
APOPTOSIS (2023) Vol. 28, Iss. 9-10, pp. 1390-1405
Closed Access | Times Cited: 23
Guang Chen, Huhu Zhang, Hongxiao Sun, et al.
APOPTOSIS (2023) Vol. 28, Iss. 9-10, pp. 1390-1405
Closed Access | Times Cited: 23
Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review
Maryam Noori, Farideh Jafari‐Raddani, Zeinab Davoodi‐Moghaddam, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Maryam Noori, Farideh Jafari‐Raddani, Zeinab Davoodi‐Moghaddam, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer
Zhen Han, Zhicheng Zhang, Xianqi Yang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008927-e008927
Open Access | Times Cited: 9
Zhen Han, Zhicheng Zhang, Xianqi Yang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008927-e008927
Open Access | Times Cited: 9
Landscape of EBV-positive gastric cancer
Motonobu Saito, Koji Kono
Gastric Cancer (2021) Vol. 24, Iss. 5, pp. 983-989
Open Access | Times Cited: 55
Motonobu Saito, Koji Kono
Gastric Cancer (2021) Vol. 24, Iss. 5, pp. 983-989
Open Access | Times Cited: 55
Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
Ruiyi Deng, Huiling Zheng, Hongzhen Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Ruiyi Deng, Huiling Zheng, Hongzhen Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Cancer Immunotherapy and Delivery System: An Update
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1630-1630
Open Access | Times Cited: 31
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1630-1630
Open Access | Times Cited: 31
Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022
Yizhen Chen, Yifan Chen, Song Tan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 18
Yizhen Chen, Yifan Chen, Song Tan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 18
Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with in-vitro and in-situ validation
Qi Wang, Ying Liu, Zhangzuo Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Qi Wang, Ying Liu, Zhangzuo Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes
Jinfeng Wang, Rilin Deng, Shuai Chen, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108414-108414
Open Access | Times Cited: 18
Jinfeng Wang, Rilin Deng, Shuai Chen, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108414-108414
Open Access | Times Cited: 18
Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy
Shanyong Yi, Mei-Zhuo Wei, Ling Zhao
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104313-104313
Closed Access | Times Cited: 7
Shanyong Yi, Mei-Zhuo Wei, Ling Zhao
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104313-104313
Closed Access | Times Cited: 7
A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer
Jianyou Zhang, Xinbo Wang, Zhonglai Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Jianyou Zhang, Xinbo Wang, Zhonglai Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression
Lijun Wu, Shiyi Cai, Yiyun Deng, et al.
International Immunopharmacology (2021) Vol. 94, pp. 107443-107443
Closed Access | Times Cited: 40
Lijun Wu, Shiyi Cai, Yiyun Deng, et al.
International Immunopharmacology (2021) Vol. 94, pp. 107443-107443
Closed Access | Times Cited: 40
The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
Jared Becerril-Rico, Eduardo Alvarado-Ortiz, Mariel E. Toledo-Guzmán, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Jared Becerril-Rico, Eduardo Alvarado-Ortiz, Mariel E. Toledo-Guzmán, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 40
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
Hiroshi Nakano, Motonobu Saito, Shotaro Nakajima, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Hiroshi Nakano, Motonobu Saito, Shotaro Nakajima, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation
Wenjie Shi, Zhilin Chen, Hui Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Wenjie Shi, Zhilin Chen, Hui Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Gastric cancer cell death analyzed by live cell imaging of spheroids
George Alzeeb, Danielle Arzur, Valérie Trichet, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
George Alzeeb, Danielle Arzur, Valérie Trichet, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention
Yanyan Shi, Huiling Zheng, Mopei Wang, et al.
Helicobacter (2022) Vol. 27, Iss. 2
Closed Access | Times Cited: 24
Yanyan Shi, Huiling Zheng, Mopei Wang, et al.
Helicobacter (2022) Vol. 27, Iss. 2
Closed Access | Times Cited: 24